FOXO4-DRI vs MOTS-c FOXO4-DRI and MOTS-c represent two fundamentally different approaches to biological aging, targeting distinct hallmarks of the aging process
Preliminary findings from these studies suggest a tolerable oral dosage of approximately 100mg/kg in mice [1]
While personal imports generally proceed without issue, occasional inspections can hold packages for days or weeks
Sever et al., 2019) or continuous alcohol consumption (Strinic et al., 2017), bupivacaine (Zivanovic-Posilovic et al., 2016), lidocaine (Stambolija et al., 2016))
Studies show improved outcomes in models of osteoarthritis and joint damage, likely mediated through growth factor upregulation and anti-inflammatory pathways
Current research does not show that BPC-157 directly causes weight loss